Literature DB >> 20071354

Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study.

Reiko Mizuno1, Shinichi Fujimoto, Yoshihiko Saito, Shinobu Nakamura.   

Abstract

AIMS: The clinical importance of cold-induced reversible myocardial ischaemia, known as cardiac Raynaud's phenomenon (C-Raynaud), has not been established in systemic sclerosis (SSc). This prospective study investigated the impact of C-Raynaud on long-term irreversible left ventricular (LV) functional and morphologic deterioration in SSc. METHODS AND
RESULTS: Fifty-one SSc patients with no clinical evidence of cardiac involvement were prospectively followed up for 7.1 +/- 2.2 years. Systolic LV dysfunction was defined as a LV ejection fraction <50%. Left ventricular remodelling was defined as an increase in LV volume during follow-up of more than 20% compared with baseline values. At the initial evaluation, C-Raynaud was found in 15 patients (29.4%). Of these, eight patients had severe C-Raynaud. None of the patients had systolic LV dysfunction. At the final evaluation, five patients had developed systolic LV dysfunction. In four of these five patients, the development of systolic LV dysfunction was associated with LV remodelling. At multivariate analysis, severe C-Raynaud was a strong independent determinant of the development of long-term systolic LV dysfunction.
CONCLUSION: This study documents for the first time that severe C-Raynaud is a strong long-term predictor of systolic LV dysfunction in SSc patients. Detection of C-Raynaud is clinically important for identifying SSc patients at high risk of cardiac deterioration at latent stage.

Entities:  

Mesh:

Year:  2010        PMID: 20071354     DOI: 10.1093/eurjhf/hfp198

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  9 in total

1.  Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection.

Authors:  Gregory J Keir; Arjun Nair; Stamatia Giannarou; Guang-Zhong Yang; Paul Oldershaw; S John Wort; Peter MacDonald; David M Hansell; Athol U Wells
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance.

Authors:  Christian Cadeddu; Martino Deidda; Giuseppina Giau; Marzia Lilliu; Fabio Cadeddu; Giulio Binaghi; Mario Nicola Mura; Michela Farci; Stefano Del Giacco; Paolo Emilio Manconi; Giuseppe Mercuro
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-30       Impact factor: 2.357

Review 3.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 4.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

5.  Replacement myocardial fibrosis at the site of late gadolinium enhancement on magnetic resonance imaging in a patient with diffuse cutaneous systemic sclerosis: An autopsy report.

Authors:  Atsushi Noguchi; Ichizo Tsujino; Noriko Oyama-Manabe; Mishie Tanino
Journal:  J Cardiol Cases       Date:  2017-05-13

Review 6.  Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases.

Authors:  Elisabetta Zanatta; Claudia Colombo; Gianpiero D'Amico; Thomas d'Humières; Carlo Dal Lin; Francesco Tona
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

7.  Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study.

Authors:  Burabha Pussadhamma; Thapanee Tipparot; Naruemol Chaosuwannakit; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara; Chingching Foocharoen
Journal:  Int J Rheumatol       Date:  2020-12-19

8.  Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test.

Authors:  Nicola Galea; Edoardo Rosato; Antonietta Gigante; Cristian Borrazzo; Andrea Fiorelli; Giovanni Barchetti; Amelia Chiara Trombetta; Maria Anna Digiulio; Marco Francone; Carlo Catalano; Iacopo Carbone
Journal:  PLoS One       Date:  2020-12-22       Impact factor: 3.240

Review 9.  Sclerodermic Cardiomyopathy-A State-of-the-Art Review.

Authors:  Adrian Giucă; Tea Gegenava; Carmen Marina Mihai; Ciprian Jurcuţ; Adrian Săftoiu; Diana Monica Gȋrniţă; Bogdan Alexandru Popescu; Nina Ajmone Marsan; Ruxandra Jurcuț
Journal:  Diagnostics (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.